Funada H, Hattori K I, Kosakai N
J Clin Microbiol. 1978 May;7(5):474-8. doi: 10.1128/jcm.7.5.474-478.1978.
A catalase-negative variant of Escherichia coli was isolated from the blood of a patient with acute leukemia who had been treated with various antibiotics and gentamicin. This small-colony variant grew almost as actively under anaerobic conditions as its large-colony revertant or E. coli NIHJ JC-2. The variant was resistant to gentamicin, in contrast with the revertant. Streptomycin and hemin stimulated growth of the variant slightly. With repeated subculturing the variant tended to increase slightly in colony size with coincident recovery of weak catalase production. The possibility that such a variant may have been induced by gentamicin was indicated.
从一名接受过多种抗生素和庆大霉素治疗的急性白血病患者血液中分离出一株过氧化氢酶阴性的大肠杆菌变异株。该小菌落变异株在厌氧条件下的生长活性几乎与其大菌落回复株或大肠杆菌NIHJ JC-2相同。与回复株相比,该变异株对庆大霉素具有抗性。链霉素和血红素对该变异株的生长有轻微刺激作用。随着反复传代培养,该变异株的菌落大小有轻微增加,同时过氧化氢酶产生能力也有微弱恢复。提示这种变异株可能是由庆大霉素诱导产生的。